|
Orthologous residues
|
|
Ets‑1 (human): T38‑p, Ets‑1 (mouse): T38‑p, Ets‑1 (rat): T38‑p, Ets‑1 (chicken): T38‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, phosphoamino acid analysis
|
|
Relevant cell lines - cell types - tissues:
3T3 (fibroblast) [Ets-2 (human)]
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
|
|
HRas (human)
|
|
increase
|
Mutation of the potential phosphorylation site threonine 38 in Ets1 or threonine 72 in Ets2 abrogates Ras superactivation.
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|